rs774543080
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017882.3(CLN6):c.395_396delCT(p.Ser132CysfsTer18) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,768 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S132S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_017882.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- ceroid lipofuscinosis, neuronal, 6AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health, Orphanet
- ceroid lipofuscinosis, neuronal, 6B (Kufs type)Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CLN6 | NM_017882.3 | c.395_396delCT | p.Ser132CysfsTer18 | frameshift_variant | Exon 4 of 7 | ENST00000249806.11 | NP_060352.1 | |
| CLN6 | NM_001411068.1 | c.491_492delCT | p.Ser164CysfsTer18 | frameshift_variant | Exon 4 of 7 | NP_001397997.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CLN6 | ENST00000249806.11 | c.395_396delCT | p.Ser132CysfsTer18 | frameshift_variant | Exon 4 of 7 | 1 | NM_017882.3 | ENSP00000249806.5 | ||
| ENSG00000260007 | ENST00000562767.2 | c.84-14138_84-14137delCT | intron_variant | Intron 1 of 2 | 3 | ENSP00000456336.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251296 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461768Hom.: 0 AF XY: 0.00000688 AC XY: 5AN XY: 727178 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ceroid lipofuscinosis, neuronal, 6A Pathogenic:3
The frameshift variant c.395_396del (p.Ser132CysfsTer18) in CLN6 gene has been reported previously in homozygous state in patients affected with lateinfantile neuronal ceroid lipofuscinosis (Wheeler et al., 2002). The p.Ser132CysfsTer18 variant is reported with the allele frequency (0.0007%) in the gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant has been reported to the ClinVar database as Pathogenic. This variant causes a frameshift starting with codon Serine 132, changes this amino acid to Cysteine residue, and creates a premature Stop codon at position 18 of the new reading frame, denoted p.Ser132CysfsTer18. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
Ceroid lipofuscinosis, neuronal, 6B (Kufs type) Pathogenic:1
- -
Ceroid lipofuscinosis, neuronal, 6A;C5561927:Ceroid lipofuscinosis, neuronal, 6B (Kufs type) Pathogenic:1
- -
See cases Pathogenic:1
- -
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21990111, 11727201, 29655203, 31589614, 30755392, 35314707, 35505348, 31440721, 36435927, 19135028) -
Neuronal ceroid lipofuscinosis Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ser132Cysfs*18) in the CLN6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLN6 are known to be pathogenic (PMID: 19135028). This variant is present in population databases (rs774543080, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with CLN6-related conditions (PMID: 11727201, 19135028). ClinVar contains an entry for this variant (Variation ID: 4082). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at